-
JUO, the Journal of Urologic Oncology, Celebrates Its Second Anniversary
- Cheol Kwak
-
J Urol Oncol. 2024;22(1):1-3.
-
Editorial
Mar 31, 2024
|
-
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
- Chang Wook Jeong
-
J Urol Oncol. 2024;22(1):4-10.
-
Invited Review
Mar 31, 2024
Prostate Cancer
|
-
Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review
- Minseok Suh, Gi Jeong Cheon
-
J Urol Oncol. 2024;22(1):11-20.
-
Invited Review
Mar 31, 2024
Prostate Cancer
|
-
High-Grade Late Urinary Toxicity Following Salvage Radiotherapy After Radical Prostatectomy: A Retrospective Cohort Study
- Seung-Kwon Choi, Myong Kim, Sang Mi Lee, et al.
-
J Urol Oncol. 2024;22(1):21-28.
-
Original Article
Mar 31, 2024
Prostate Cancer
|
-
Enzalutamide Maintenance Following Docetaxel in Metastatic Castration-Naive Prostate Cancer: A Pilot Feasibility Study
- Sung Hee Lim, Sung Wook Cho, Jae Hoon Chung, et al.
-
J Urol Oncol. 2024;22(1):29-33.
-
Original Article
Mar 31, 2024
Prostate Cancer
|
-
Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis
- Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, et al.
-
J Urol Oncol. 2024;22(1):34-41.
-
Systemic Review and Meta-analysis
Mar 31, 2024
Kidney Cancer
|
-
Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
- Jung Hoon Kim, Ji Woong Hwang
-
J Urol Oncol. 2024;22(1):42-51.
-
Original Article
Mar 31, 2024
Kidney Cancer
|
-
Prognostic Factors and Cancer-Specific Survival of Surgically Managed Renal Cell Carcinoma With Venous Thrombus: A 30-Year Experience at a Tertiary Referral Center
- Hyun Young Lee, Yunjoong Kim, Bumjin Lim, et al.
-
J Urol Oncol. 2024;22(1):52-58.
-
Original Article
Mar 31, 2024
Kidney Cancer
|
-
Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
- Joohyun Hong, Ghee Young Kwon, Minyong Kang, et al.
-
J Urol Oncol. 2024;22(1):59-67.
-
Original Article
Mar 31, 2024
Kidney Cancer
|
-
Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
- Sung Han Kim, Ilma S. Savul, Seth P. Lerner
-
J Urol Oncol. 2024;22(1):68-77.
-
Invited Review
Mar 31, 2024
Bladder Cancer
|
-
Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
- Stefani Frost, Parisa Ziarati, Ryan Moen, et al.
-
J Urol Oncol. 2024;22(1):78-94.
-
Systemic Review and Meta-analysis
Mar 31, 2024
Bladder Cancer
|
-
Declaration of Conflict of Interest for Editorial Board Members’ Articles
-
-
J Urol Oncol. 2024;22(1):95-96. Corrects: J Urol Oncol 2023;21(1):5 Corrects: J Urol Oncol 2023;21(1):14 Corrects: J Urol Oncol 2023;21(1):23 Corrects: J Urol Oncol 2023;21(1):53 Corrects: J Urol Oncol 2023;21(1):59 Corrects: J Urol Oncol 2023;21(1):79 Corrects: J Urol Oncol 2023;21(2):140
-
Erratum
Mar 31, 2024
|